Literature DB >> 9810462

Cochlear implantation in osteogenesis imperfecta.

J Szilvássy1, J Jóri, J Czigner, F Tóth, Z Szilvássy, J G Kiss.   

Abstract

A case is reported in which a Nucleus 22 channel intracochlear implant was applied to a Hungarian woman (age 50 yr) with profound deafness associated with osteogenesis imperfecta. Successful intracochlear insertion of the 22 electrodes resulted in a 70 dB hearing improvement at frequencies 250-2000 HZ. Nevertheless, a characteristic facial twitching appeared upon activation of electrodes 9-13. Inactivation of these electrodes abolished the non-acoustic nerve excitation with preservation of acoustic performance. Osteogenesis imperfecta may involve a state of risk for non-acoustic nerve activation in cochlear implant patients possibly resulting from a reduced impedance to current spread by abnormal bone tissue. This, however can be overcome by simple programming manoeuvres.

Entities:  

Mesh:

Year:  1998        PMID: 9810462

Source DB:  PubMed          Journal:  Acta Otorhinolaryngol Belg        ISSN: 0001-6497


  3 in total

Review 1.  Osteogenesis imperfecta: practical treatment guidelines.

Authors:  F Antoniazzi; M Mottes; P Fraschini; P C Brunelli; L Tatò
Journal:  Paediatr Drugs       Date:  2000 Nov-Dec       Impact factor: 3.022

2.  Treatments for hearing loss in osteogenesis imperfecta: a systematic review and meta-analysis on their efficacy.

Authors:  Maialen Ugarteburu; Luis Cardoso; Claus-Peter Richter; Alessandra Carriero
Journal:  Sci Rep       Date:  2022-10-12       Impact factor: 4.996

3.  Hearing loss in osteogenesis imperfecta: characteristics and treatment considerations.

Authors:  Joseph P Pillion; David Vernick; Jay Shapiro
Journal:  Genet Res Int       Date:  2011-12-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.